A clinical scoring system for predicting tumor recurrence after percutaneous radiofrequency ablation for 3 cm or less hepatocellular carcinoma

A clinical scoring system for predicting tumor recurrence after percutaneous radiofrequency ablation for 3 cm or less hepatocellular carcinoma

Abstract Preoperative prediction of tumor recurrence after radiofrequency ablation (RFA) in patients with early hepatocellular carcinoma (HCC) is helpful for clinical decision-making before treatment. A total of 162 patients with HCC of 3 cm or less who were completely ablated by percutaneous RFA we...

Full description

Bibliographic Details
Main Authors: Yong Zhu He, Kun He, Rui Qin Huang, Li Wen Liu, Shao Wei Ye, Jun Lin Qian, Peng Peng, Qi Jie Luo, Ze Liang Wang, Ze Min Hu
Format: Article
Language:English
Published: Nature Publishing Group 2021-04-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-021-87782-y

Internet

https://doi.org/10.1038/s41598-021-87782-y

Similar Items